{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T10:11:27Z","timestamp":1779358287812,"version":"3.51.4"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ZS Kardiologie"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1007\/s00392-005-0245-y","type":"journal-article","created":{"date-parts":[[2005,7,28]],"date-time":"2005-07-28T02:58:45Z","timestamp":1122519525000},"page":"510-515","source":"Crossref","is-referenced-by-count":20,"title":["Euro heart failure survey","Euro Heart Survey: Unzureichende Umsetzung der aktuellen Leitlinien bei der medikament\u00f6sen Therapie der chronischen Herzinsuffizienz"],"prefix":"10.1007","volume":"94","author":[{"given":"K.","family":"Drechsler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Dietz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. C.","family":"Wollert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Storp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Molling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Zeymer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Niebauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"245_CR1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","volume":"353","author":"Cibis","year":"1999","unstructured":"Cibis. II Investigators and Committees (1999) The cardiac insufficiency bisoprolol study II: a randomized trial. Lancet 353:9\u201313","journal-title":"Lancet"},{"key":"245_CR2","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1136\/bmj.321.7269.1095","volume":"321","author":"Cleland","year":"2000","unstructured":"Cleland JG, Clark A, Caplin JL (2000) Taking heart failure seriously. BMJ 321(7269):1095\u20131096","journal-title":"BMJ"},{"key":"245_CR3","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0195-668X(02)00700-5","volume":"24","author":"Cleland","year":"2003","unstructured":"Cleland JG, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC, Dietz R, Gavazzi A, Hobbs R, Korewicki J, Madeira HC, Moiseyev VS, Preda I, van Gilst WH, Widimsky J, Freemantle N, Eastaugh J, Mason J (2003) The Euro-Heart Failure survey programme\u2014a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 24:464\u2013474","journal-title":"Eur Heart J"},{"key":"245_CR4","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1053\/euhj.1999.1762","volume":"21","author":"Cohen-Solal","year":"2000","unstructured":"Cohen-Solal A (2000) A national survey of heart failure in French hospitals. Eur Heart J 21:763\u2013769","journal-title":"Eur Heart J"},{"key":"245_CR5","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/eurheartj\/ehi115","volume":"26","author":"Flather","year":"2005","unstructured":"Flather MD, Shibata MC, Coats AJ, Van Veldhuisen DJ, Parkhomenko A, Borbola J, Cohen-Solal A, Dumitrascu D, Ferrari R, Lechat P, Soler-Soler J, Tavazzi L, Spinarova L, Toman J, B\u00f6hm M, Anker SD, Thompson SG, Poole-Wilson PA (2005) Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS) Eur Heart J 26:215\u2013225","journal-title":"Eur Heart J"},{"key":"245_CR6","first-page":"1657","volume":"100","author":"Fliser","year":"2003","unstructured":"Fliser D (2003) Symptomatische Hyperkali\u00e4mie: Deutsches \u00c4rzteblatt 100:1657\u20131659","journal-title":"Deutsches \u00c4rzteblatt"},{"key":"245_CR7","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s003920170187","volume":"90","author":"Hoppe","year":"2001","unstructured":"Hoppe UC, Erdmann E (2001) Leitlinien zur Therapie der chronischen Herzinsuffizienz. Z Kardiol 90:218\u2013237","journal-title":"Z Kardiol"},{"key":"245_CR8","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1056\/NEJMoa040135","volume":"351","author":"Juurlink","year":"2004","unstructured":"Juurlink DN, Mamdani MM, Lee DS, Kopp A, Austin PC, Laupacis A, Redelmeier DA (2004) Rates of hyperkalemia after publication of the randomized aldactone evaluation study. N Engl J Med 351:543\u2013551","journal-title":"N Engl J Med"},{"key":"245_CR9","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","volume":"353","author":"MERIT-HF","year":"1999","unstructured":"MERIT-HF study group (1999) Effect of Metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL randomized intervention trial in congestive heart failure (MERIT-HF). Lancet 353:2001\u20132007","journal-title":"Lancet"},{"key":"245_CR10","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1053\/euhj.1998.1239","volume":"20","author":"Mosterd","year":"1999","unstructured":"Mosterd A, Hoes AW, de Bruyne MC, Deckers JW, Linker DT, Hofman A, Grobbee DE (1999) Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. Eur Heart J 20(6):447\u2013455","journal-title":"Eur Heart J"},{"key":"245_CR11","first-page":"45","volume":"4","author":"Ormiston","year":"2003","unstructured":"Ormiston TM, Salpeter SR (2003) Beta-blocker use in patients with heart failure and concomitant obstructive airway disease: moving from myth to evidence-based practice. Heart Fail Monit 4(2):45\u201354","journal-title":"Heart Fail Monit"},{"key":"245_CR12","first-page":"139","volume":"2","author":"The","year":"1999","unstructured":"The Study Group on Diagnosis of the Working Group on Heart Failure of The European Society of Cardiology (1999) Increasing awareness and improving the management of heart failure in Europe: the IMPROVEMENT of HF initiative. Eur J Heart Fail 2:139\u2013144","journal-title":"Eur J Heart Fail"}],"container-title":["Zeitschrift f\u00fcr Kardiologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-005-0245-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00392-005-0245-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-005-0245-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T16:20:19Z","timestamp":1559060419000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00392-005-0245-y"}},"subtitle":["Medical treatment not in line with current guidelines"],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":12,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["245"],"URL":"https:\/\/doi.org\/10.1007\/s00392-005-0245-y","relation":{},"ISSN":["0300-5860","1435-1285"],"issn-type":[{"value":"0300-5860","type":"print"},{"value":"1435-1285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}